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The successful application of
chronic dialysis and/ or renal transplantation to patients with chronic
uremia has sometimes obscured the
fact that significant progress has
also been made in our understanding of other therapeutic approaches
to chronic renal failure. These less
dramatic advances are commonly
labeled "conservative" in nature, yet
they have contributed decisively to
the welfare of many uremic patients
by improving their sense of wellbeing and delaying their need for
such types of therapy as regularly
repetitive dialysis. I shall comment
first on certain general principles of
management and then review some
of the scientific therapeutic maneuvers and concepts that comprise the
main foundation for the so-called
conservative management of chronic
uremia. Although my remarks are
directed primarily toward patients
with progressive primary renal disease, they are of equal pertinence
to patients with renal failure of several types or etiologies.
General Principles of
Management
The progressive destruction of
renal tissue effects an ever changing
clinical pattern in which new and
different signs and symptoms ap-
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pear at differing rates in individual
patients. All would agree that conservative therapy should be initiated
prior to the appearance of terminal
renal failure, but general agreement has not yet been reached on
the exact time at which certain
dietary programs should be started
during the earlier phases of disease.
Nevertheless, once therapy has been
initiated, additional conservative
measures must be added until the
entire conservative armamentarium ,
including an occasional dialysis, becomes insufficient to sustain useful
life. Chronic dialysis and/ or renal
transplantation must then be considered. It is important to realize
that conservative therapy, dialysis,
and transplantation must be combined carefully for best results. One
of these therapeutic approaches
cannot be used to the exclusion of
the others. Certainly the institution of chronic dialysis does not
eliminate the need for conservative
therapy. Optimal treatment reflects
a continuum of effort utilizing several therapeutic concepts and modalities.
If I can assume today that we
are dealing with an azotemic patient whose underlying renal disease is irreversible, our first management responsibility should be
the exclusion of factors that may
have reversibly intensified the degree of azotemia. In order to appreciate the unique importance of
reversible factors in the treatment

of chronic uremia, we must also
understand the well-established relationship between changes of the
blood-urea-nitrogen (BUN) concentration and the creatinine clearance
or any other index of filtration
rate. From an analysis of Figure 1 it is evident that the BUN
concentration varies inversely with
associated changes of filtration rate.
Although the BUN concentration
rises with the earliest reduction of
filtration rate, it ordinarily does not
exceed the upper limits of normal
until the filtration rate has been
reduced to between 25 % and 50 %
of normal. Furthermore, from any
point of departure, a 50 % reduction of the filtration rate can be
expected to effect a corresponding
twofold increase of the BUN concentration . Obviously the patient
whose filtration rate is only 10 ml/
min, or approximately 10 % of a
hypothetically normal value, cannot
afford to sustain a further 50 % reduction of filtration rate, even transiently. All other factors being
constant, a transient reduction of
filtration rate from 10 to 5 ml per
minute might be accompanied by an
increase of the BUN concentration
from, perhaps, 75 to 150 mg per
100 ml.
The relationship between functioning renal mass and the signs
and symptoms of renal failure can
be described similarly (Fig. 1).
When the limits of renal reserve
have been exceeded, uremic sympMCV QUARTERLY 4(4): 156-161, 1968
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Fig. I-Relationship between creatinine clearance and the blood-ureanitrogen concentration.

toms appear rapidly in association
with further and much smaller reductions in renal mass, and the
condition of the patient deteriorates
alarmingly. This disproportionate
progression of clinical symptomatology may be associated with little
change in the actual rate of histologic progression of the disease.
Obviously, at this point, a small
absolute reduction in function is
of great importance to the patient.
Thus, the correction of reversible
factors that transiently reduce renal
function is a primary and urgent
responsibility of the physician .
Table 1 lists a few of the many
factors that may contribute to a
transient and potentially reversible
reduction of filtration rate in patients with severe renal disease.
Congestive heart failure is certain ly one of the most common clinical occurrences that may intensify
renal failure reversibly; its appearance is almost always associated
with some degree of filtration rate
depression. Its correction may make
the difference between clinical compensation and progressive uremia.
Cautious digitalization and/ or diuretic therapy, or even dialysis, may
be required for the removal of excess water and electrolytes. If digitalization is necessary, both the initial and maintenance doses must be
reduced, since digitalis is normally
excreted by the kidneys.
Next, one must realize that active
bacterial pyelonephritis can exist in
the absence of fever, chills, or
C .V .A. tenderness, and that a urine

culture should be mandatory in
every patient with chronic renal disease. The presence of a systemic infection with fever and tissue injury
can markedly accelerate the development of azotemia by increasing
protein catabolism and the subsequent presentation of nitrogenous
products to the organ for excretion.
Correctable causes of urinary tract
obstruction must also be sought.
Intravenous orography is the safest
technique for such a diagnostic
search, but special roentgenographic
techniques utilizing large doses of
contrast media may be required
in patients with severe renal failure.
Lastly, the presence of salt
and/ or water depletion, when
viewed collectively, represents an
extremely common event leading to
a reversible intensification of renal
failure. Gastrointestinal losses from
nausea and vomiting or even overnight water restriction for a concentration test or an intravenous
urogram may initiate a serious
chain of events. A decrease in extracellular volume leads to a reduc~
tion in filtration rate and a decrease
in urine flow, thereby compromising still further the excretory efficiency of an already damaged kidney.
Factors such as those in Table
1, if present, must be identified
promptly and corrected judiciously.
Once this is accomplished , the efforts of the physician can then be
directed toward the specific management of other uremic signs and
symptoms.
In simplified fashion, Figure 2
depicts an essential characteristic of
the functional response of the diseased kidney to variations in the
excretory load of water, nitrogenous products, or electrolytes.
Although the functional response
of the residual nephron population
may be perfectly normal in a qualitative sense, it may be Jacking in
another important respect-namely,
in the flexibility of its response.
The diseased kidney is unable to
compensate rapidly and efficiently

for associated changes in the volume or composition of the body
fluids. As illustrated by the solid
arrows, the normal kidney can
rapidly and effectively adjust its
rate of excretion to dispose of a
wide range of excretory loads, so
that excretion can equal intake plus
production minus internal degradation . If the excretory load is large,
the healthy kidney quickly increases
excretion to equal the load ; if the
excretory load is reduced, renal excretion is reduced efficiently and
appropriately. In contrast, as shown
by the dashed-line arrows, the
range of excretory adjustments by
the diseased kidney to similar loads
is restricted severely. When the load
is large, the excretory capacity may
be insufficient to effect complete
disposal ; when the load is reduced
sharply, the capacity to reduce excretion (conservation) may be insufficient to prevent the appearance
of a body deficit. Excretory adjustments cannot be increased to the
usual maximum or decreased to the
usual minimum. As a consequence,
both excess and deprivation are
tolerated poorly. It then becomes
the responsibility of the physician
to adjust the intake to equal the excretory capacity instead of depending on the functional response of
a damaged organ to make the necessary excretory adjustments.
Specific Management Problems
An incomplete list of specific
management problems or considerations that must be entertained is
given in Table 2. Those items followed by an asterisk can be approached at least partially by appropriate adjustment of dietary intake.
Their very number offers mute
testimony to the fact that dietary
therapy affords a major foundation
for the management of chronic
uremia.
First, let us consider the adjustment of water intake in nonoliguric patients with severe chonic
uremia. In such patients, water excess with dilutional hyponatremia is
157
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TABLE 1
Reversible Causes of Filtration
Rate Depression in Patients with
Underlying Renal Disease
1. Congestive heart failure

2. Infection
a. Genitourinary
b. Systemic
3. Urinary tract obstruction
4. Salt and water depletion

TABLE 2
Management Considerations
1. Salt and water requirements*

2. Control of azotemia and maintenance of nitrogen balance*
3. Hyperkalemia *
4. Acidosis*
5. Anemia
6. Infection

7. Other:
a. Hypertension
b. Edema and/ or heart failure*
c. Bone disease
d. Uremic syndrome: nausea,
vomiting, pruritus, malaise,
CNS irritability, etc.*
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Fig. 2-Renal response to complete
dietary sodium restriction in health
and renal disease.
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a frequent consequence of aggressive fluid therapy. This phenomenon
may be seen when a conscious patient with chronic uremia is asked
to force fluids for the performance
of an ill-advised P .S.P. test. Occasionally, excessive fluid intake
is prescribed because of the
mistaken impression that renal
function can be improved. The
modest reduction in azotemia that
may occur as a consequence of such
a maneuver may be viewed as the
net effect of hemodilution and a
modest increase in urine flow; it
does not reflect an improvement of
glomerular filtration. Dilutional hyponatremia may also appear, simply
because the intake of water has
been increased above the excretory
capacity of the damaged kidneys.
In many patients, a suitable intake
of water is that which is dictated
by thirst. In other patients whose
filtration rate may be reduced more
severely, certainly below 5 ml/min,
the intake of water may have to be
adjusted so that it exceeds an already near-maximal urine output by
no more than 300 to 400 ml per
day. In such patients, water retention may occur if the total daily
fluid intake, perhaps even including dietary water, is increased to a
value no higher than 1500 ml. Consequently, an arbitrary and ideal
fluid intake that is suitable for all
patients cannot be identified. Rather,
maximal fluid intakes can be ascertained only by serial observations
of body weight, urine output, and
fluid intake. Conversely, despite the
fact that gross water wasting is rare
in chronic renal failure, one may
find patients with obligatory minimal urine volumes consequent to
an endogenous solute diuresis which
may be as high as 2 liters/ day.
Such patients may rapidly become
water-depleted if intake is restricted
for any ill-advised reason. Drugs
that cause nausea must be used
with caution, and hospital procedures that promote dehydration
should not be employed. Obviously,
a water deficit, if present, should
be treated appropriately.

The existence of chronic renal
disease should not be equated with
a necessity for sodium restriction .
In fact, in the absence of edema
and, perhaps, severe hypertension,
rigid dietary sodium restriction is
contraindicated. As renal failure
progresses, the diseased kidney
loses its normal capacity to alter
sodium excretion over a wide range.
In contrast to the usual sequence
during good health when renal sodium conservation is extremely efficient (Fig. 3), the diseased kidney cannot reduce urine sodium
excretion maximally, even after a
relatively Jong period of dietary
deprivation. Although the daily
quantitative deficit is small, a larger
and significant cumulative deficit
may occur over a more protracted
period. Sodium may be lost in the
urine in small amounts even in the
presence of a falling concentration
of serum sodium. Hyponatremia
will occur if the patient drinks excess electrolyte-free water or loses
sodium in excess of water via other
routes. The loss of GI secretions
by vomiting or diarrhea represents
another important cause of sodium
depletion. Replacement of fluids
with salt-free solutions such as 5 %
dextrose in water may restore extracellular volume at the cost of
hyponatremia. Sodium depletion
may be facilitated further by the
injudicious use of potent diuretics
in patients whose dietary sodium
has been rigidly restricted. It is
important to remember that the
residual nephron population can effect a significant increase in fractional sodium excretion in response
to the use of potent diuretics such
as furosemide, even when the filtration rate is as low as I ml/min.
Once again, the quantitative daily
deficit may be small, but long-term
diuretic therapy may contribute to
the appearance of a significant sodium deficit.
Conversely, when the dietary salt
intake is increased, the patient with
renal disease may be unable to excrete the same sodium load that
could have been handled with ease
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by a patient with normal renal
function. Sodium intake must be
kept sufficiently low to avoid sodium excess. Ideally, one would
prefer to maintain the sodium intake at a level that is somewhat
below that amount which is capable of inducing sodium excess. In
practice, the upper limits must be
defined individually for each patient, since they are not predictable
with confidence. Most importantly,
one must also realize that both the
upper and lower limits of sodium
excretory adjustments may change
with the passage of time and the
progression of disease. In the absence of edema or congestive heart
failure, it is our own practice to
initiate therapy with a 5 gm or 85
millimol salt (NaCl) diet. If sodium bicarbonate is required for
the treatment of systemic acidosis,
the dietary intake of sodium chloride may have to be reduced equivalently. In other patients, even
greater amounts of sodium chloride
may be tolerated safely. On admission, some patients may exhibit
unrecognized salt depletion with
plasma volume contraction and filtration rate reduction. The judicious
administration of salt and water,
with subsequent stabilization of the
body weight somewhat above the
admission weight, as well as a measurable increase of creatinine clearance strongly suggest that salt depletion was present. After replacement, the maintenance salt intake is
prescribed at a level somewhat below the defined upper limits of excretory capacity.
Important complications of, or
contraindications to, an excessive
salt intake are hypertension or the
appearance of a congestive state.
With certain exceptions, there is
general agreement that the treatment of hypertension can be accomplished satisfactorily with drugs
in the usual nonoliguric patient. In
such patients, the hazards of rigid
dietary sodium restriction would
seem to weigh the small contribution of dietary sodium restriction to the control of diastolic hy-

pertension. Of course, in patients
whose renal function is so reduced
that repetitive dialysis is required,
rigid limitation of the dietary intake of salt and water may well be
necessary to control hypertension
and prevent salt and water excess.
The choice of anti-hypertensive
drugs rests largely on the experience
of the physician. Apresoline, alphamethyldopa, and guanethedine have
all been used successfully.
The data in Table 3 reflect an
average expression of the traditional
views of most physicians regarding
dietary protein restriction. Theoretically, dietary protein restriction
might be expected to minimize the
intensity of systemic acidosis, and
there is good evidence to support
the notion that the reduction of
azotemia may restore a sense of
well-being to patients who complain
of malaise, anorexia, nausea, and
vomiting. There is somewhat less
agreement as to just when dietary
protein should be restricted in patients with early renal failure. Certainly, there is little evidence that
azotemia, itself, is harmful to the
asymptomatic patient with mild and
uncomplicated renal failure, and
in such a patient there may be little
basis for rigid dietary protein restriction. The indications for dietary
protein restriction in Table 3 admittedly are arbitrary, but they are
in agreement with common practice at many institutions. The usual
low-protein hospital diet necessitates
a protein intake at the indicated
level, if negative nitrogen balance
is to be avoided . Overall, the goal
of protein restriction is to reduce
protein catabolism while simultaneously avoiding the hazards of nitrogen depletion. To this end, dietary protein restriction should be
coupled with the provision of adequate protein-sparing calories such
as carbohydrate and fat, the prevention and treatment of infection,
the encouragement of maximal
tolerable ambulation, the avoidance
of unnecessary surgery and manipulation, the provision of anabolic
steroids, and the avoidance of inhi-

bitors of protein anabolism such
as tetracycline and adrenal glucocorticoids.
Recently, two European
investigators, Giordano (1967)
and Giovannetti (1967), have
been associated with an increased interest in the control of
uremic symptoms by dietary management. Their own clinical results
have been impressive, and most
would agree that the morbidity of
chronic uremia appears to have
been lessened significantly by their
dietary efforts. Basically, these investigators have demonstrated that
nitrogen balance can be maintained and that protein depletion
can be avoided by the provision of
remarkably low nitrogen diets if
the dietary protein is comprised of
proteins of high biological value.
Nitrogen balance has been maintained in patients with chronic
uremia on a dietary protein intake
as low as 15 to 20 gm per
day. Marked clinical improvement
has been observed simultaneously.
Anorexia, nausea, vomiting, fatigue, twitching, and mental
changes have disappeared completely or decreased significantly.
The severity of anemia has been
ameliorated in a few patients. Fundamentally, low-protein diets are
directed toward control of the

TABLE 3
Dietary Protein Restriction in
Renal Failure
Rationale:

1) Diminished accumulation of
metabolic acid,
urea, and other
nitrogenous products

Indications: 1) Azotemia
(BUN> 50
mg/ 100 ml)
2) Hyperphosphatemia
3) Acidosis
Amount:

1) 0.5 to 0.6 gm per
kg plus urinary
losses
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Fig. 3-Efficiency of renal sodium conservation by the normal and diseased
kidneys.

serious nutritional defects that are
characterized by weight loss, profound weakness, and gross evidence
of decreased muscle mass. In the
past, concern over the nutritional
status of the uremic patient was often considered futile, because the
presence of severe nausea and
vomiting appeared to prevent adherence to an effective nutritional
regimen. Obviously, if malnutrition
is to be avoided, a diet for uremic
patients should contain sufficient
calories to exert a maximal protein-sparing action and sufficient
amino acids of appropriate quality
and quantity to promote optimal
protein synthesis without increasing the degree of azotemia.
In patients whose creatimne
clearances were as low as 5 ml/
min, Giovannetti has shown that
the institution of a basal diet containing small amounts (12 gm) of
high biological protein can be associated with a simultaneous decrease
in both azotemia and the negativity
of overall nitrogen balance. The
further addition of essential amino
acids in amounts sufficient to increase the total protein intake to between 15 and 20 gm was followed
by the appearance of slightly posi160

tive nitrogen balance without an attendant increase in azotemia. Similar results were achieved when egg
protein was utilized instead of individual essential amino acids. For
practical purposes, the additional
nitrogen, as essential amino acids,
appeared to be utilized completely
without inducing a measurable increase in overall protein catabolism.
Furthermore, the urease-induced
elaboration of ammonia nitrogen in
the gut provided a pathway for the
re-utilization of endogenous urea
nitrogen for protein synthesis. One
important fact that emerges from
these studies is the realization that
it is possible to improve the nutrition of the uremic patient via the
provision of extremely low-protein
diets of high biologic value, and
that their use may be associated
with striking clinical improvement,
even in individuals with severe filtration reduction.
Unfortunately, the diets of Giordano and Giovannetti are much
better suited to Italian than American tastes. Recently, however, a
variety of similar low-protein diets
have appeared in this country and
seem to offer great promise. Monotony, rather than palatability,

constitutes the major barrier to
their acceptance by the patient.
Basically, these diets consist of appropriate fruits and vegetables,
other sources of carbohydrate and
fat, and egg protein. Recently, lactalbumin from electrodialyzed whey
has been utilized as a protein source
of high biologic value. It can be offered to the patient as a reasonably
palatable, albeit monotonous, milkshake-like drink. These diets prohibit the use of flour in any form,
and special baking recipes have
proliferated, each of which utilizes
pure wheat starch. Low-protein
bakery products of wheat starch
can be quite satisfactory, although
baking with wheat starch does pose
many culinary problems for the
housewife. These products are fastrising, and ho usewives must learn
to initiate the baking process in a
cold oven rather than one that has
been prewarmed, if they are to
avoid a product that has a consistency resembling castiron. At present, at least one commercial company with national distribution is
experimenting with a ready-mix
baking product of wheat starch that
may prove to be satisfactory and
originative. As long as facilities are
so limited that the patient's admittance to repetitive dialysis must be
delayed, the extra effort involved
in these dietary manipulations
would appear to justify their time
and expense.
Acidosis (Table 3 ) is a constant
feature of chronic uremia that
should be controlled, because it may
lead to such adverse events as an
extracellular shift of potassium and
the appearance of hyperkalemia, increased respiratory effort, anorexia,
somnalence, bony demineralization,
and even, perhaps, reduction in the
effectiveness of endogenous insulin.
Efforts directed toward minimizing
protein catabolism also decrease
the endogenous production of fixed
acid, and the provision of an additional buffer such as sodium bicarbonate helps to neutralize the effects of excess metabolic acid. We
prefer to utilize sodium bicarbo-
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nate, rather then sodium lactate,
in a daily dose sufficient to
maintain the plasma bicarbonate
concentration between 18 and
20 mmole per liter. The lactate
anion, as you are aware, must first
be metabolized, and there is some
evidence that the hepatic degradation of lactate may be significantly
impaired in uremia. If edema is
present and sodium bicarbonate
therapy is required, it is obvious
that the dietary intake of sodium
chloride may have to be reduced in
order to keep the total dietary sodium intake within the desired
range. Unfortunately, in some patients, one may have to accept an
incomplete control of acidosis if
aggravation of congestive heart failure by sodium salt administration
is to be avoided. Peritoneal dialysis
provides a convenient way of correcting severe acidosis without a n
associated net addition of sodium
to the body.
Several therapeutic maneuvers
may be utilized in the management
of acute hyperkalemia (Table 3).
It is true that serious hyperkalemia
is uncommon in the usual nonoliguric p atient with chronic renal
failure. On the other hand, a marginal and persistent elevation of the
serum potassium concentration is
rather frequent in our experience.
The correction of acidosis alone
will often facilitate the control of
this type of hyperkalemia. An adjustment of sodium intake may also
be of importance. We have seen
patients on rigid dietary sodium restriction in whom the provision of
increased dietary sodium was accompanied by a reduction in modest hyperkalemia, perhaps as a consequence of the increased availability of sodium within those portions
of the nephron where sodium-potassium-hydrogen exchange occurs.
Sodium-cycle cation exchange resins may be used effectively in
small daily maintenance doses.
Since their use contributes to the
dietary intake of sodium, an appropriate reduction of dietary sodium
may be necessary if the control of

sodium balance is important. Lastly,
the appearance of hyperkalemia can
be minimized greatly by moderate
dietary restriction, an avoidance of
potassium-containing drugs, and
prompt control of increased catabolism due to fever, etc.
Anemia is probably best untreated, unless it is symptomatic
(undue fatigue, angina, etc.) or
unusually severe and complicated
by bleeding or excessive hemolysis.
The etiology of the anemia of
chronic renal failure, in the most
general terms, can be related to the
net effect of bone marrow suppression, increased hemolysis (perhaps
as a consequence of an extracellular
hemolysin) , defective erythropoietin production by the kidney, and
bleeding. Transfusion is the treatment of choice, and maintenance of
the hematocrit between 18 and 25
vol% is generally adequate for the
relief of symptoms. A further increase serves little purpose, and the
short-lived survival time of even
fresh red cells in uremic patients
often means that repeated transfusions will be necessary. Since the
restoration of volume is not a consideration, the use of fresh-packed
red cells is preferable. Other types
of therapy have been tried (vitamin
B12, cobalt salts, etc.) , but their use
is often impractical, and predictable
benefits have not been observed.
Time does not permit detailed
discussion of all the items listed in
Table 3. However, in closing, I
would like to comment briefly on
just a few additional therapeutic approaches. The use of anabolic
agents has some degree of merit,
in my opinion. It is difficult to establish proof in a given individual that
agents such as norethandrolone or
oxandrolone really contribute to the
management of uremia, although, in
perhaps a third of the patients, some
decrease in protein catabolism and
azotemia may be observed. If an
anabolic agent is utilized, one with
minimal virilizing effects should be
chosen. Pruritus can be controlled
in some patients by the use of selected antihistamines; symptomatic

relief of nausea can be provided by
many members of the phenothiazine family. Finally, the control of
hyperuricemia is deserving of comment. Whether or not hyperuricemia should be controlled at all is,
perhaps, problematic. There is little factual evidence as to whether
hyperuricemia per se contributes
either to progression of the underlying disease or to uremic symptomatology. H ypothetically, either circumstance is possible. Empirically,
we have treated several patients
with allopurinol, a potent inhibitor
of xanthine oxidase. Therapy has
been restricted to patients with
marked hyperuricemia ( > 12 mg/
100 ml), and impressive reductions
of the plasma uric acid concentration have been observed. Nevertheless, further investigation is required
to establish the real benefits of such
therapy.
In closing, I would emphasize
that I have failed to discuss many
equally impor tant aspects of conservative management. Uremia is a
strange disease; it is a difficult illness for the patient, and it is one
that requires careful preparation of
the family for long-term involvement. If dialysis or transplantation
cannot be performed, our minimal
objective should be the provision of
life that is at least as comfortable as
possible. For the most part, this objective can be achieved with proper
attention to the selection of tools
from our conservative armamentarium.
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